Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04424004 · ClinicalTrials.gov registry record

MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study

A clinical trial, sponsored by Duke University.

Completed
Registry status
300
Enrollment target

NCT04424004 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 300 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04424004 has completed, sponsored by Duke University.

COMPLETED
Registry status
300 participants
Enrollment target

Study Summary

The objectives of this research is to: * Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies using the MURDOCK Study Community Registry and Biorepository population as a measure of these features in Cabarrus County through a biweekly electronic survey. * Estimate the prevalence and change in prevalence of COVID-19 infection based on responses to questionnaire items on symptoms and practices using a biweekly electronic survey. * Among respondents to the baseline questionnaire, conduct at home mid-turbinate nasal swab collection for viral PCR testing for active COVID-19 infection as an estimate of the prevalence of active infection in Cabarrus County. * Among respondents to the baseline questionnaire, conduct serologic testing for IgG antibodies to SARS-CoV-2 as an estimate of the prevalence of exposure and potential immunity to COVID-19.

Interventions

  • OTHER COVID-19 PCR and serology testing

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2020-06-09
Est. Completion 2021-12-02

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04424004

The ClinicalTrials.gov registry entry for NCT04424004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which COVID-19 PCR and serology testing is the first listed.

NCT04424004 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04424004 about?

NCT04424004 is a clinical study titled "MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study". The objectives of this research is to: * Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies using the MURDOCK Study Community Registry and Biorepository population as a measure of these features in Cabarrus County through a biweekly electronic sur...

What is the current status of trial NCT04424004?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2020-06-09. Estimated completion is 2021-12-02.

What interventions are being tested in trial NCT04424004?

The interventions under investigation include: COVID-19 PCR and serology testing (OTHER).

Who is sponsoring clinical trial NCT04424004?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.